Markers of inflammation and disuse in vastus lateralis of chronic obstructive pulmonary disease patients

No abstract is available for this paper.

• Publication year

  2007

• Venue

  European Journal of Clinical Investigation

• Publication date

  2007-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1365-2362.2007.01867.xPMID 17883420
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Elevated Levels of IL-18 in Plasma and Skeletal Muscle in Chronic Obstructive Pulmonary Disease

  2007cited by this paper
• Prevalence of nutritional depletion in a large out-patient population of patients with COPD.

  2006cited by this paper
• NF-kappa B-mediated MyoD decay during muscle wasting requires nitric oxide synthase mRNA stabilization, HuR protein, and nitric oxide release.

  2005cited by this paper
• THIS ARTICLE HAS BEEN RETRACTED Exercise induces interleukin‐8 expression in human skeletal muscle

  2005cited by this paper
• Interleukin-6 Causes Myocardial Failure and Skeletal Muscle Atrophy in Rats

  2005cited by this paper
• Hypoxaemia enhances peripheral muscle oxidative stress in chronic obstructive pulmonary disease

  2005cited by this paper
• Characteristics of physical activities in daily life in chronic obstructive pulmonary disease.

  2005cited by this paper
• NF-κB-Mediated MyoD Decay during Muscle Wasting Requires Nitric Oxide Synthase mRNA Stabilization, HuR Protein, and Nitric Oxide Release

  2005cited by this paper
• Skeletal muscle inflammation and nitric oxide in patients with COPD

  2005cited by this paper
• IKKbeta/NF-kappaB activation causes severe muscle wasting in mice.

  2004cited by this paper
• Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis

  2004cited by this paper
• Proinflammatory cytokine impairment of insulin-like growth factor I-induced protein synthesis in skeletal muscle myoblasts requires ceramide.

  2004cited by this paper
• Differential cytokine gene expression in the diaphragm in response to strenuous resistive breathing.

  2004cited by this paper
• Effects of fluticasone on systemic markers of inflammation in chronic obstructive pulmonary disease.

  2004cited by this paper
• CHRONIC OBSTRUCTIVE PULMONARY DISEASE Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I

  2003cited by this paper
• Exercise-induced quadriceps oxidative stress and peripheral muscle dysfunction in patients with chronic obstructive pulmonary disease.

  2003cited by this paper
• Transcriptional regulation of IGF-I expression in skeletal muscle.

  2003cited by this paper
• Increased tumour necrosis factor-alpha plasma levels during moderate-intensity exercise in COPD patients.

  2003cited by this paper
• Endotoxin Stimulates In Vivo Expression of Inflammatory Cytokines Tumor Necrosis Factor Alpha, Interleukin-1&bgr;, -6, and High-Mobility-Group Protein-1 in Skeletal Muscle

  2003cited by this paper
• Pulmonary vascular involvement in chronic obstructive pulmonary disease

  2003cited by this paper
• Testosterone administration to older men improves muscle function: molecular and physiological mechanisms.

  2002cited by this paper
• Weakness of respiratory and skeletal muscles after a short course of steroids in patients with acute lung rejection

  2002cited by this paper
• Control of growth by the somatropic axis: growth hormone and the insulin-like growth factors have related and independent roles.

  2001cited by this paper
• Postnatal profiles of myogenic regulatory factors and the receptors of TGF-β2, LIF and IGF-I in the gastrocnemius and rectus femoris muscles of dy mouse

  2000cited by this paper
• Regulation of IGF‐I, IGFBP‐4 and IGFBP‐5 gene expression by loading in mouse skeletal muscle

  1999cited by this paper
• Effect of high dose inhaled steroid on cells, cytokines, and proteases in induced sputum in chronic obstructive pulmonary disease.

  1999cited by this paper
• Altered gene expression in steroid-treated denervated muscle.

  1999cited by this paper
• Myogenin, MyoD, and myosin heavy chain isoform expression following hindlimb suspension.

  1999cited by this paper
• Acute treatment with corticosteroids decreases IGF-1 and IGF-2 expression in the rat diaphragm and gastrocnemius.

  1999cited by this paper
• Chronic obstructive pulmonary disease: capillarity and fiber-type characteristics of skeletal muscle.

  1998cited by this paper
• Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD.

  1997cited by this paper
• Corticosteroid-induced myopathy of the respiratory muscles.

  1994cited by this paper
• Selective accumulation of MyoD and myogenin mRNAs in fast and slow adult skeletal muscle is controlled by innervation and hormones.

  1993cited by this paper
• Insulin-like growth factor binding protein-1 inhibits the mitogenic effect of insulin-like growth factors and progestins in human endometrial stromal cells.

  1993cited by this paper
• Corticosteroid-induced myopathy involving respiratory muscles in patients with chronic obstructive pulmonary disease or asthma.

  1992cited by this paper
• Insulin-like growth factor-I stimulates terminal myogenic differentiation by induction of myogenin gene expression.

  1991cited by this paper
• Corticosteroid-induced myopathy and the respiratory muscles. Report of two cases.

  1989cited by this paper
• Cachectin/TNF or IL-1 alpha induces cachexia with redistribution of body proteins.

  1989cited by this paper
• Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

  1979cited by this paper

• Lower-Limb Muscle Impairments in Patients with COPD: An Overview of the Past Decade

  2026cites this paper
• Association between muscular atrophy and mortality risk in patients with COPD: a systematic review

  2024cites this paper
• Musculoskeletal crosstalk in chronic obstructive pulmonary disease and comorbidities: Emerging roles and therapeutic potentials.

  2024cites this paper
• Main Pathogenic Mechanisms and Recent Advances in COPD Peripheral Skeletal Muscle Wasting

  2023cites this paper
• Revisiting Skeletal Muscle Dysfunction and Exercise in Chronic Obstructive Pulmonary Disease: Emerging Significance of Myokines

  2023cites this paper
• The Importance of the Interleukin-8 Study in Chronic Obstructive Pulmonary Disease

  2023cites this paper
• Impaired regenerative capacity contributes to skeletal muscle dysfunction in chronic obstructive pulmonary disease (COPD).

  2022cites this paper
• Assessment of pulmonary functions and peripheral muscle strength of COPD patients in different GOLD stages

  2022cites this paper
• Deaccelerated Myogenesis and Autophagy in Genetically Induced Pulmonary Emphysema.

  2022cites this paper
• Impaired muscle stem cell function and abnormal myogenesis in acquired myopathies

  2022cites this paper
• Angiotensin II Type 2 Receptor Potentiates Skeletal Muscle Satellite Cell Differentiation via the GSK3β/β-catenin Pathway AT2R regulates GSK3β signaling in satellite cells

  2022cites this paper
• COPD_A_280540 25..40

  2021cites this paper
• LncRNA CASC2 is involved in the development of chronic obstructive pulmonary disease via targeting miR-18a-5p/IGF1 axis

  2021cites this paper
• Towards Personalized Management of Sarcopenia in COPD

  2021cites this paper
• Role of acute exacerbations in skeletal muscle impairment in COPD

  2020cites this paper
• Is inflammatory signaling involved in disease-related muscle wasting? Evidence from osteoarthritis, chronic obstructive pulmonary disease and type II diabetes.

  2020cites this paper
• Mechanisms of IGF-1-Mediated Regulation of Skeletal Muscle Hypertrophy and Atrophy

  2020cites this paper
• CD34 regulates the skeletal muscle response to hypoxia

  2019cites this paper
• Fibroblast Growth Factor 23 is Associated with a Frequent Exacerbator Phenotype in COPD: A Cross-Sectional Pilot Study

  2019cites this paper
• Rehabilitation in chronic respiratory diseases: In‐hospital and post‐exacerbation pulmonary rehabilitation

  2019cites this paper
• Change in skeletal muscle associated with unplanned hospital admissions in adult patients: A systematic review and meta-analysis

  2019cites this paper
• Insulin-Like Growth Factor-1 Signaling in Lung Development and Inflammatory Lung Diseases

  2018cites this paper
• Skeletal Muscle Dysfunction in Chronic Obstructive Pulmonary Disease. What We Know and Can Do for Our Patients

  2018cites this paper
• Muscle wasting in osteoarthritis model induced by anterior cruciate ligament transection

  2018cites this paper
• The role of ambulatory oxygen to improve skeletal muscle gene expression in Chronic Obstructive Pulmonary Disease in patients with exercise induced hypoxaemia

  2018cites this paper
• Relevance of nutritional support and early rehabilitation in hospitalized patients with COPD.

  2018cites this paper
• Deterioration of Limb Muscle Function during Acute Exacerbation of Chronic Obstructive Pulmonary Disease

  2017cites this paper
• Explorer Genome-wide mRNA expression profiling in vastus lateralis of COPD patients with low and normal fat free mass index and healthy controls

  2017cites this paper
• Pulmonary rehabilitation for patients with acute chronic obstructive pulmonary disease exacerbations: is the evidence strengthening?

  2017cites this paper
• Comorbidities: Assessment and Treatment

  2017cites this paper
• ACE and response to pulmonary rehabilitation in COPD: two observational studies

  2017cites this paper
• Molecular mechanism of sarcopenia and cachexia: recent research advances

  2017cites this paper
• Reduced nuclear translocation of serum response factor is associated with skeletal muscle atrophy in a cigarette smoke-induced mouse model of COPD

  2017cites this paper
• An Intronic Enhancer Element Regulates Angiotensin II Type 2 Receptor Expression during Satellite Cell Differentiation, and Its Activity Is Suppressed in Congestive Heart Failure*

  2016cites this paper
• Changes in structural and metabolic muscle characteristics following exercise-based interventions in patients with COPD: a systematic review

  2016cites this paper
• Impaired regeneration: A role for the muscle microenvironment in cancer cachexia.

  2016cites this paper
• Acute exercise amplifies inflammation in obese patients with COPD.

  2016cites this paper
• Contribution of the Mitochondria to Locomotor Muscle Dysfunction in Patients With COPD.

  2016cites this paper
• Molecular and biological pathways of skeletal muscle dysfunction in chronic obstructive pulmonary disease

  2016cites this paper
• Augmenting pulmonary rehabilitation in chronic obstructive pulmonary disease: studies of ACE-inhibition and nitrate supplementation

  2016cites this paper
• Frontiers in Skeletal Muscle Wasting, Regeneration and Stem Cells

  2016cites this paper
• A doença pulmonar obstrutiva crónica e o exercício: impacto da doença no declínio funcional e importância do treino de exercício nos benefícios para a saúde

  2016cites this paper
• Tetrastigma hemsleyanum ( Sanyeqing ) extracts reduce inflammation and oxidative stress in a chronic obstructive pulmonary disease rat model

  2016cites this paper
• Prevalence of quadriceps muscle weakness in patients with COPD and its association with disease severity

  2015cites this paper
• Muscle dysfunction in chronic obstructive pulmonary disease: update on causes and biological findings.

  2015cites this paper
• Respiratory and Limb Muscle Dysfunction in COPD

  2015cites this paper
• Epigenetics and muscle dysfunction in chronic obstructive pulmonary disease.

  2015cites this paper
• Cachexia in chronic obstructive pulmonary disease: new insights and therapeutic perspective

  2015cites this paper
• Prevalence of quadriceps muscle weakness in patients with COPD and its association with disease severity

  2015cites this paper
• dysfunction in COPD The mechanisms of cachexia underlying muscle

  2015cites this paper
• An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease.

  2014cites this paper
• Preserved function and reduced angiogenesis potential of the quadriceps in patients with mild COPD

  2014cites this paper
• Effect of Rehabilitation Program on Endocrinological Parameters in Patients with COPD and in Healthy Subjects

  2014cites this paper
• Systemic and pulmonary inflammation is independent of skeletal muscle changes in patients with chronic obstructive pulmonary disease

  2014cites this paper
• Systemic and pulmonary inflammation is independent of skeletal muscle changes in patients with chronic obstructive pulmonary disease

  2014cites this paper
• Early pulmonary rehabilitation for exacerbations of chronic obstructive pulmonary disease

  2014cites this paper
• Respiratory and Non-respiratory Muscle Dysfunction in COPD

  2014cites this paper
• Circulating microRNA in Chronic Obstructive Pulmonary Disease

  2014cites this paper
• The manifestations of ageing in the pathophysiology of skeletal muscle dysfunction in COPD

  2014cites this paper
• Structural alterations of skeletal muscle in copd

  2014cites this paper
• Invited Topical Review Physiotherapy management of acute exacerbations of chronic obstructive pulmonary disease

  2014cites this paper
• Systemic and pulmonary inflammation is independent of skeletal muscle changes in patients with chronic obstructive pulmonary disease

  2014cites this paper
• Physiotherapy management of acute exacerbations of chronic obstructive pulmonary disease.

  2014cites this paper
• Evaluation of anabolic hormone status in patients with COPD during stableand acute exacerbation state.

  2014cites this paper
• Musculoskeletal Disorders in Chronic Obstructive Pulmonary Disease

  2014cites this paper
• Ageing and the border between health and disease

  2014cites this paper
• Molecular mechanisms mediating development of pulmonary cachexia in COPD

  2014influential citation
• Regenerative defect in vastus lateralis muscle of patients with chronic obstructive pulmonary disease

  2014cites this paper
• Systemic and pulmonary inflammation is independent of skeletal muscle changes in patients with chronic obstructive pulmonary disease

  2014cites this paper
• Should all patients with COPD be exercise trained?

  2013cites this paper
• Adiposity in COPD

  2013cites this paper
• Exercise and COPD: Therapeutic Responses, Disease-Related Outcomes, and Activity-Promotion Strategies

  2013cites this paper
• Mechanisms of striated muscle dysfunction during acute exacerbations of COPD.

  2013cites this paper
• The Lung Inflammation and Skeletal Muscle Wasting Induced by Subchronic Cigarette Smoke Exposure Are Not Altered by a High-Fat Diet in Mice

  2013cites this paper
• ACE-inhibition and skeletal muscle dysfunction in chronic obstructive pulmonary disease

  2013cites this paper
• The mechanisms of cachexia underlying muscle dysfunction in COPD.

  2013cites this paper
• Muscle Dysfunction in COPD Mechanisms of striated muscle dysfunction during acute exacerbations of COPD

  2013influential citation
• Triggers and mechanisms of skeletal muscle wasting in chronic obstructive pulmonary disease.

  2013cites this paper
• Short term and long term effects of pulmonary rehabilitation on physical activity in COPD.

  2012cites this paper
• Respiratory diseases and muscle dysfunction

  2012cites this paper
• Intrinsic skeletal muscle alterations in chronic heart failure patients: a disease-specific myopathy or a result of deconditioning?

  2012cites this paper
• Evaluation of the Significance of Circulating Insulin-Like Growth Factor-1 and C-Reactive Protein in Patients with Chronic Obstructive Pulmonary Disease

  2012cites this paper
• MAPK signaling in the quadriceps of patients with chronic obstructive pulmonary disease.

  2012cites this paper
• Renin-angiotensin system blockade: a novel therapeutic approach in chronic obstructive pulmonary disease.

  2012cites this paper
• IGF1 and IGFBP3 in acute respiratory distress syndrome.

  2012cites this paper
• Physiopathologie de la bronchopneumopathie chronique obstructive

  2012cites this paper
• Effect of rehabilitation program on GH/IGF-1/IGF-BP3 axis and Testosterone/Cortisol ratio in patients with COPD and in healthy subjects

  2012influential citation
• Skeletal Muscle Dysfunction and Pulmonary Rehabilitation in COPD

  2012cites this paper
• Physical activity, nutritional status and systemic inflammation in COPD

  2012cites this paper
• Prospects for the development of effective pharmacotherapy targeted at the skeletal muscles in chronic obstructive pulmonary disease: a translational review

  2012cites this paper
• p38 Mitogen-activated Protein Kinase is Not Activated in the Quadriceps of Patients with Stable Chronic Obstructive Pulmonary Disease

  2012cites this paper
• Sarcopenia and cachexia: the adaptations of negative regulators of skeletal muscle mass

  2012cites this paper
• Muscle function in COPD: a complex interplay

  2012cites this paper
• Title: IGF1 and IGFBP3 in the Acute Respiratory Distress Syndrome Running Title: IGF1 and IGFBP3 in ARDS

  2011cites this paper
• IGF 1 and IGFBP 3 in acute respiratory distress syndrome

  2011cites this paper
• Non-invasive ventilation (NIV) as an aid to rehabilitation in acute respiratory disease

  2011cites this paper
• Relationship Between Peripheral Muscle Structure and Function in Patients With Chronic Obstructive Pulmonary Disease With Different Nutritional Status

  2011cites this paper
• Inflammatory cells and apoptosis in respiratory and limb muscles of patients with COPD.

  2011cites this paper
• [Diaphragm and skeletal muscle dysfunction in COPD].

  2011cites this paper
• Structural and functional changes of peripheral muscles in chronic obstructive pulmonary disease patients

  2010cites this paper